Lianyungang, China

Jingyang Zhang

This inventor holds 2 USPTO granted patents. Top assignees: Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Shengdi Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jingyang Zhang. Retrieved from https://idiyas.com/inventor/jingyang-zhang-h2ta0bev

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jingyang Zhang: Innovator in Kidney Disease Treatment

Introduction

Jingyang Zhang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of medicine, particularly in the treatment of kidney diseases. His innovative approach has led to the development of a patent that holds promise for improving patient outcomes.

Latest Patents

Jingyang Zhang holds a patent for the "Application of JAK inhibitor in kidney disease." This patent outlines the use of a JAK inhibitor in the preparation of a drug aimed at treating or preventing kidney disease. This advancement is crucial as it opens new avenues for therapeutic interventions in a field that requires urgent solutions.

Career Highlights

Zhang is currently associated with Jiangsu Hengrui Pharmaceuticals Co., Ltd., a leading pharmaceutical company in China. His work at this institution has allowed him to focus on innovative research and development in the pharmaceutical sector. His dedication to advancing medical science is evident through his patent and ongoing research efforts.

Collaborations

Zhang collaborates with Lu Su, a talented female researcher who contributes to his projects. Their partnership exemplifies the importance of teamwork in scientific research and innovation.

Conclusion

Jingyang Zhang's contributions to kidney disease treatment through his patent demonstrate his commitment to advancing medical science. His work at Jiangsu Hengrui Pharmaceuticals Co., Ltd. and collaboration with Lu Su highlight the collaborative nature of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…